Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 15,600 IMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | ImageneBio, Inc. (IMA) | Grant/Award | 15,600 | n/a |
| Jun 3, 2026 | CVRx, Inc. (CVRX) | Grant/Award | 8,720 | n/a |
| Apr 8, 2026 | Replimune Group, Inc. (REPL) | Grant/Award | 44,500 | n/a |
| Dec 29, 2025 | ImageneBio, Inc. (IMA) | Purchase | 16,000 | $95.8K |
| Dec 22, 2025 | ImageneBio, Inc. (IMA) | Grant/Award | 31,200 | n/a |
| Jun 5, 2025 | CVRx, Inc. (CVRX) | Grant/Award | 19,554 | n/a |
| Apr 4, 2025 | Replimune Group, Inc. (REPL) | Grant/Award | 32,000 | n/a |
| Aug 20, 2024 | Morphic Holding, Inc. (MORF) | Disposition to Issuer | 9,066 | n/a |
| Aug 15, 2024 | CVRx, Inc. (CVRX) | Purchase | 3,000 | $24.3K |
| Aug 8, 2024 | CVRx, Inc. (CVRX) | Purchase | 3,000 | $24.7K |